Healthcare technology news, life science current events. Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs December saw a slew of executive hires, promotions, exits and layoffs ...

Nov 12, 2024 · Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform.

May 28, 2024 · Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction.

GE HealthCare made a slew of announcements at RSNA 2024, including an acquisition, new machines for mammography and SPECT/CT imaging, and new AI features to help improve radiologist workflows.

Mar 10, 2024 · Health systems aren’t seeing a ton of ROI when it comes to their AI investments quite yet, as use of the technology is still in an iterative stage. However, Mount Sinai CEO Brendan Carr thinks ...

Feb 25, 2024 · One concern about the GLP-1 class of metabolic disorder drugs is that the weight patients lose includes muscle as well as fat. BioAge Labs wants to test whether its experimental medication, dosed ...

GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025 Combining AI-driven insights with tailored care pathways, patients ...

Oct 16, 2024 · The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells.

Oct 23, 2024 · GE HealthCare is launching a new AI platform that harmonizes cancer patients’ data and provides clinicians with summaries of their notes and reports. The platform, called CareIntellect for ...

Nov 19, 2024 · Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giant’s top ...